← Leaderboards
Trudy Gale Oliver
University Of Utah
$9,454,558
Attributed
$16,035,420
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,035,420 · 8
By mechanism
R01$6,496,604 · 4
U24$6,056,429 · 1
U01$3,057,810 · 1
R21$358,342 · 1
P30$66,235 · 1
Top collaborators
- Ramaswamy Govindan5 shared
- Obi L. Griffith5 shared
- Lauren Averett Byers4 shared
- John D Minna4 shared
- Charles M Rudin4 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorInnovationGenetically Engineered MouseMissionUnited States National Institutes Of HealthMalignant Neoplasm Of LungCessation Of LifeNew Therapeutic TargetSurvival RateTreatment StrategyCancer PatientMalignant NeoplasmsDisease ModelIn VivoCancer CellPublic HealthQuality Of LifeBiological MarkersHuman DiseaseClinical TrialsResponseMouse ModelChemotherapyCells
Grant awards (30)
Coordinating center for the NCI small cell lung cancer research consortium$1,379,839
U24 · FY2025 · CA
NEUROD1 function in SCLC fate and plasticity$535,073
R01 · FY2025 · CA · contact PI
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer$389,699
R01 · FY2025 · CA · contact PI
Coordinating center for the NCI small cell lung cancer research consortium$1,456,493
U24 · FY2024 · CA
NEUROD1 function in SCLC fate and plasticity$550,323
R01 · FY2024 · CA · contact PI
Pro-tumor functions of neutrophils in squamous cell lung cancer$390,763
R01 · FY2024 · CA · contact PI
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer$370,215
R01 · FY2024 · CA · contact PI
Coordinating center for the NCI small cell lung cancer research consortium$1,565,497
U24 · FY2023 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer$403,102
R01 · FY2023 · CA · contact PI
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer$381,906
R01 · FY2023 · CA · contact PI
Coordinating center for the NCI small cell lung cancer research consortium$1,654,600
U24 · FY2022 · CA
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$567,348
U01 · FY2022 · CA
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer$381,905
R01 · FY2022 · CA · contact PI
Pro-tumor functions of neutrophils in squamous cell lung cancer$66,555
R01 · FY2022 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$561,139
U01 · FY2021 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer$389,613
R01 · FY2021 · CA · contact PI
Mechanisms of Arginine Deprivation in Small Cell Lung Cancer$369,125
R01 · FY2021 · CA · contact PI
Pro-tumor functions of neutrophils in squamous cell lung cancer$332,837
R01 · FY2021 · CA · contact PI
Cell Response and Regulation (CRR)$66,235
P30 · FY2021 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$778,924
U01 · FY2020 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer$389,613
R01 · FY2020 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$560,803
U01 · FY2019 · CA
Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer$193,042
R21 · FY2019 · CA · contact PI
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer$589,596
U01 · FY2018 · CA
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer$309,175
R01 · FY2018 · CA · contact PI
Identifying Therapeutic Vulnerabilities of c-MYC-driven Small Cell Lung Cancer$165,300
R21 · FY2018 · CA · contact PI
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer$309,175
R01 · FY2017 · CA · contact PI
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer$309,175
R01 · FY2016 · CA · contact PI
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer$309,175
R01 · FY2015 · CA · contact PI
Identifying Mechanisms of Sox2-Driven Squamous Cell Lung Cancer$309,175
R01 · FY2014 · CA · contact PI